These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8249139)

  • 1. The effect of portal venous tolerance on the survival of small bowel allografts in the rat.
    Nakafusa Y; Goss JA; Roland CR; Flye MW
    Transplantation; 1993 Nov; 56(5):1279-82. PubMed ID: 8249139
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effect of portal venous tolerance on survival of vascularized organ allografts.
    Nakafusa Y; Goss JA; Roland CR; Flye MW
    Transplant Proc; 1994 Jun; 26(3):1621. PubMed ID: 8030061
    [No Abstract]   [Full Text] [Related]  

  • 3. Portal venous drainage is not beneficial in multivisceral small bowel allografts.
    D'Silva M; Candinas D; Hubscher SG; McMaster P
    Transplant Proc; 1996 Oct; 28(5):2475-6. PubMed ID: 8907910
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts.
    Bollinger RB; Yamaguchi Y; Harland RC; Wyble C; Mori K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):213-4. PubMed ID: 2495602
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor-specific tolerance to cardiac, but not renal, allografts is induced by intrathymic transfer of donor splenocytes.
    Nakafusa Y; Goss JA; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):292-4. PubMed ID: 8438305
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclooxygenase blockade abrogates the prolonged survival resulting from drainage of rat cardiac allografts into the portal vein.
    Kamei T; Callery MP; Flye MW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):591-2. PubMed ID: 1899312
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of passenger leukocytes in the immunogenicity of intestinal and cardiac allografts in the rat.
    Gundlach M; Oluwole S; D'Agati V; Chabot J; Broelsch CE; Hardy MA
    Transplant Proc; 1992 Jun; 24(3):1131-2. PubMed ID: 1604552
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of perioperative portal venous administration of donor lymphocytes on survival of rat cardiac allografts and renal grafts of the mongrel dog.
    Hirakawa K; Yoshimura N; Lee CJ; Yasui H; Ohsaka Y; Hamashima T; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):346-7. PubMed ID: 8438328
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells.
    Chowdhury NC; Fawwaz RA; Oluwole SF
    J Surg Res; 1993 Apr; 54(4):368-74. PubMed ID: 8331931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of FK 506 on the survival of rat small bowel allografts.
    Takeda Y; Okajima K; Iga C; Date K; Ryo T; Niki M; Asaka K; Tezuka K; Isozaki H
    Transplant Proc; 1991 Dec; 23(6):3251. PubMed ID: 1721426
    [No Abstract]   [Full Text] [Related]  

  • 11. Small-bowel transplantation following portal venous injection of donor strain spleen cells.
    Wolf YG; Dunaway DJ; Harmel RP
    Transplant Proc; 1990 Dec; 22(6):2493-4. PubMed ID: 2264122
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):286-8. PubMed ID: 8438302
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of FK 506 on graft survival in rat small intestinal allografts.
    Date K; Okajima K; Takeda Y; Isozaki H; Tezuka K; Ryo T
    Transplant Proc; 1992 Jun; 24(3):1173. PubMed ID: 1376516
    [No Abstract]   [Full Text] [Related]  

  • 14. Duration of donor-specific tolerance after intrathymic administration of alloantigen.
    Arima T; Nakafusa Y; Goss JA; Walp LA; Yu S; Flye MW
    Transplant Proc; 1995 Feb; 27(1):136-7. PubMed ID: 7878912
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonspecific transplant-induced immunosuppression of second renal allografts in the rat.
    Mahoney RJ; Sakai A; Murray IM
    Transplant Proc; 1977 Mar; 9(1):1087-92. PubMed ID: 325737
    [No Abstract]   [Full Text] [Related]  

  • 16. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of small bowel allografts after intrathymic injection of donor alloantigen and ALS.
    Goss JA; Nakafusa Y; Flye MW
    J Surg Res; 1993 May; 54(5):494-8. PubMed ID: 8361174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to cardiac allografts induced in utero with fetal liver cells.
    Yuh DD; Gandy KL; Hoyt G; Reitz BA; Robbins RC
    Circulation; 1996 Nov; 94(9 Suppl):II304-7. PubMed ID: 8901765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens.
    Nagano H; Monden M; Gotoh M; Tanigawa T; Nakano Y; Tono T; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):352-3. PubMed ID: 8438331
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells.
    Yu S; Nakafusa Y; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):500-1. PubMed ID: 8438394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.